Emerging Trends in Neuropalliative Care: A Palliative Approach to Epilepsy and Seizure Management in Adults

Anna-Christin Willert; Alexander Bernhard Kowski

doi:10.1055/s-0044-1787808

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2024; 44(05): 567-573
DOI: 10.1055/s-0044-1787808

Review Article

Emerging Trends in Neuropalliative Care: A Palliative Approach to Epilepsy and Seizure Management in Adults

Autor*innen

Anna-Christin Willert

¹Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Berlin, Germany
Alexander Bernhard Kowski

¹Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Berlin, Germany

Abstract

Management of severe (drug-resistant) epilepsy and epilepsy in other serious illnesses is multidimensional and requires consideration of both physical symptoms and psychosocial distress that require individualized treatment. Palliative care offers a holistic approach to disease that focuses on all dimensions of suffering to maintain quality of life. Integration of a palliative care mind- and skillset in the management of severe epilepsy and epilepsy in other serious illnesses can provide person-centered care and support for families and caregivers.

Keywords

epilepsy - seizures - neuropalliative care

Volltext

Referenzen

References
1 Ben-Menachem E, Schmitz B, Kälviäinen R, Thomas RH, Klein P. The burden of chronic drug-refractory focal onset epilepsy: can it be prevented?. Epilepsy Behav 2023; 148: 109435
2 Beghi E. The epidemiology of epilepsy. Neuroepidemiology 2020; 54 (02) 185-191
3 WHO. Accessed October 1, 2023 at: https://www.who.int/news-room/fact-sheets/detail/epilepsy
4 Collaborators GBDN. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18 (05) 459-480
5 Collaborators GBDE. GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18 (04) 357-375
6 Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults. Lancet 2019; 393 (10172): 689-701
7 Sen A, Jette N, Husain M, Sander JW. Epilepsy in older people. Lancet 2020; 395 (10225): 735-748
8 Scheffer IE, Berkovic S, Capovilla G. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 512-521
9 Kwan P, Arzimanoglou A, Berg AT. et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51 (06) 1069-1077
10 Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V. The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis. Epilepsia 2018; 59 (12) 2179-2193
11 Sultana B, Panzini MA, Veilleux Carpentier A. et al. Incidence and prevalence of drug-resistant epilepsy: a systematic review and meta-analysis. Neurology 2021; 96 (17) 805-817
12 Weber J, Gustafsson C, Malmgren K. et al. Evaluation for epilepsy surgery - why do patients not proceed to operation?. Seizure 2019; 69: 241-244
13 de Tisi J, Bell GS, Peacock JL. et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 2011; 378 (9800) 1388-1395
14 Kelley AS. Defining “serious illness”. J Palliat Med 2014; 17 (09) 985
15 Radbruch L, De Lima L, Knaul F. et al. Redefining palliative care-a new consensus-based definition. J Pain Symptom Manage 2020; 60 (04) 754-764
16 Thurman DJ, Logroscino G, Beghi E. et al; Epidemiology Commission of the International League Against Epilepsy. The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 2017; 58 (01) 17-26
17 Tombini M, Assenza G, Quintiliani L, Ricci L, Lanzone J, Di Lazzaro V. Epilepsy and quality of life: what does really matter?. Neurol Sci 2021; 42 (09) 3757-3765
18 Saada F, Wang ZS, Bautista RED. In focus: The everyday lives of families of adult individuals with epilepsy. Epilepsy Behav 2015; 50: 10-13
19 Thompson PJ, Upton D. The impact of chronic epilepsy on the family. Seizure 1992; 1 (01) 43-48
20 Stefan H, May TW, Pfäfflin M. et al. Epilepsy in the elderly: comparing clinical characteristics with younger patients. Acta Neurol Scand 2014; 129 (05) 283-293
21 Weller M, Stupp R, Wick W. Epilepsy meets cancer: when, why, and what to do about it?. Lancet Oncol 2012; 13 (09) e375-e382
22 Siebenbrodt K, Willems LM, von Podewils F. et al. Determinants of quality of life in adults with epilepsy: a multicenter, cross-sectional study from Germany. Neurol Res Pract 2023; 5 (01) 41
23 Athira SB, Pal P, Nair PP, Nanda N, Aghoram R. Influence of sleep disturbance, depression, anxiety, and stress on quality of life in people with epilepsy. Epileptic Disord 2024; 26 (01) 69-78
24 Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997; 38 (03) 353-362
25 Mula M, Cock HR. More than seizures: improving the lives of people with refractory epilepsy. Eur J Neurol 2015; 22 (01) 24-30
26 Loring DW, Meador KJ, Lee GP. Determinants of quality of life in epilepsy. Epilepsy Behav 2004; 5 (06) 976-980
27 Zhu XR, Zhao T, Gu H. et al. High risk of anxiety and depression in caregivers of adult patients with epilepsy and its negative impact on patients' quality of life. Epilepsy Behav 2019; 90: 132-136
28 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55 (04) 475-482
29 Clark D. ‘Total pain’, disciplinary power and the body in the work of Cicely Saunders, 1958-1967. Soc Sci Med 1999; 49 (06) 727-736
30 Kluger BM, Hudson P, Hanson LC. et al. Palliative care to support the needs of adults with neurological disease. Lancet Neurol 2023; 22 (07) 619-631
31 Shorvon S, Tomson T. Sudden unexpected death in epilepsy. Lancet 2011; 378 (9808) 2028-2038
32 Shen S, Dong Z, Sander JW, Zhou D, Li J. Somatic symptoms and related disorders in a large cohort of people with epilepsy: a cohort study. Epilepsia 2023; 64 (02) 320-334
33 Fiest KM, Dykeman J, Patten SB. et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013; 80 (06) 590-599
34 Rudzinski LA, Meador KJ. Epilepsy and neuropsychological comorbidities. Continuum (Minneap Minn) 2013; 19 (3 Epilepsy): 682-696
35 Gesche J, Antonson S, Dreier JW, Christensen J, Beier CP. Social outcome and psychiatric comorbidity of generalized epilepsies - a case-control study. Epilepsia 2021; 62 (05) 1158-1169
36 Willems LM, Zöllner JP, Hamann L. et al. Unemployment and early retirement among patients with epilepsy - a study on predictors, resilience factors and occupational reintegration measures. Epilepsy Behav 2023; 144: 109255
37 Bauer PR, Bronnec MLA, Schulze-Bonhage A, Altenmüller DM, Fuchs T. Seizures as a struggle between life and death: an existential approach to the psychosocial impact of seizures in candidates for epilepsy surgery. Psychopathology 2023; 56 (06) 417-429
38 Jacoby A, Ring A, Whitehead M, Marson A, Baker GA. Exploring loss and replacement of loss for understanding the impacts of epilepsy onset: a qualitative investigation. Epilepsy Behav 2014; 33: 59-68
39 Velissaris SL, Wilson SJ, Saling MM, Newton MR, Berkovic SF. The psychological impact of a newly diagnosed seizure: losing and restoring perceived control. Epilepsy Behav 2007; 10 (02) 223-233
40 Drees C, Hixon AM, Sillau S. et al. Physician distress when treatments fail. Survey on physician distress when treating persons with drug-resistant epilepsy and knowledge of neuropalliative care. Epilepsy Behav 2023; 140: 108925
41 Bernacki RE, Block SD. American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med 2014; 174 (12) 1994-2003
42 RamachandranNair R, Jack SM. SUDEP: What do adult patients want to know?. Epilepsy Behav 2016; 64 (Pt A): 195-199
43 Xu Z, Ayyappan S, Seneviratne U. Sudden unexpected death in epilepsy (SUDEP): what do patients think?. Epilepsy Behav 2015; 42: 29-34
44 Harden C, Tomson T, Gloss D. et al. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2017; 88 (17) 1674-1680
45 Holtkamp M, May T, Berkenfeld R. et al. Erster epileptischer Anfall und Epilepsien im Erwachsenenalter, S2k-Leitlinie. Deutsche Gesellschaft für Neurologie. 2023 . Accessed November 1, 2023 at: www.dgn.org/leitlinien
46 Solomon AJ, Macauley R, Spencer D. Epileptologists infrequently discuss the risk of intubation with patients with epilepsy in the United States. Ann Palliat Med 2021; 10 (04) 3626-3632
47 Creutzfeldt CJ, Robinson MT, Holloway RG. Neurologists as primary palliative care providers: communication and practice approaches. Neurol Clin Pract 2016; 6 (01) 40-48
48 Pace A, Dirven L, Koekkoek JAF. et al; European Association of Neuro-Oncology palliative care task force. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol 2017; 18 (06) e330-e340
49 Koekkoek JAF, Dirven L, Reijneveld JC. et al. Epilepsy in the end of life phase of brain tumor patients: a systematic review. Neurooncol Pract 2014; 1 (03) 134-140
50 Oberndorfer S, Lindeck-Pozza E, Lahrmann H, Struhal W, Hitzenberger P, Grisold W. The end-of-life hospital setting in patients with glioblastoma. J Palliat Med 2008; 11 (01) 26-30
51 Nauck F, Alt-Epping B. Crises in palliative care–a comprehensive approach. Lancet Oncol 2008; 9 (11) 1086-1091
52 Willert A-C, Ploner CJ, Kowski AB. Causes for emergency hospitalization of neurological patients with palliative care needs. Front Neurol 2021; 12: 674114
53 Wiese CHR, Vossen-Wellmann A, Morgenthal HC, Popov AF, Graf BM, Hanekop GG. Emergency calls and need for emergency care in patients looked after by a palliative care team: retrospective interview study with bereaved relatives. BMC Palliat Care 2008; 7: 11-11
54 Pompili A, Telera S, Villani V, Pace A. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients. Neurosurg Focus 2014; 37 (06) E5
55 Grönheit W, Popkirov S, Wehner T, Schlegel U, Wellmer J. Practical management of epileptic seizures and status epilepticus in adult palliative care patients. Front Neurol 2018; 9: 595-595
56 Kälviäinen R, Reinikainen M. Management of prolonged epileptic seizures and status epilepticus in palliative care patients. Epilepsy Behav 2019; 101 (Pt B): 106288
57 Koekkoek JAF, Postma TJ, Heimans JJ, Reijneveld JC, Taphoorn MJB. Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study. Support Care Cancer 2016; 24 (04) 1633-1638
58 Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol 2014; 117 (02) 217-224
59 Kienitz R, Kay L, Beuchat I. et al. Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs 2022; 36 (09) 951-975
60 Bond KR, Rea E, Lawthom C. Seizures in palliative medicine: brivaracetam. BMJ Support Palliat Care 2023; 13 (e2): e308-e310
61 Rémi C, Zwanzig V, Feddersen B. Subcutaneous use of lacosamide. J Pain Symptom Manage 2016; 51 (02) e2-e4
62 Sutherland A, Meldon C, Harrison T, Miller M. Subcutaneous levetiracetam for the management of seizures at the end of life: an audit and updated literature review. J Palliat Med 2021; 24 (07) 976-981
63 Rémi C, Hermann A, Krull E, Ockert-Schön F, Rémi J. Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment. Int J Clin Pharm 2023; 45 (03) 774-780
64 Kondasinghe JS, Look ML, Moffat P, Bradley K. Subcutaneous levetiracetam and sodium valproate use in palliative care patients. J Pain Palliat Care Pharmacother 2022; 36 (04) 228-232
65 Levira F, Thurman DJ, Sander JW. et al; Epidemiology Commission of the International League Against Epilepsy. Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 2017; 58 (01) 6-16
66 Blank LJ, Acton EK, Willis AW. Predictors of mortality in older adults with epilepsy: implications for learning health systems. Neurology 2021; 96 (01) e93-e101
67 Keezer MR, Bell GS, Neligan A, Novy J, Sander JW. Cause of death and predictors of mortality in a community-based cohort of people with epilepsy. Neurology 2016; 86 (08) 704-712
68 Walczak TS, Leppik IE, D'Amelio M. et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001; 56 (04) 519-525
69 Mohanraj R, Norrie J, Stephen LJ, Kelly K, Hitiris N, Brodie MJ. Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study. Lancet Neurol 2006; 5 (06) 481-487
70 Thurman DJ, Hesdorffer DC, French JA. Sudden unexpected death in epilepsy: assessing the public health burden. Epilepsia 2014; 55 (10) 1479-1485
71 Tomson T, Nashef L, Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol 2008; 7 (11) 1021-1031
72 Sutter R, Marsch S, Fuhr P, Rüegg S. Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study. Epilepsia 2013; 54 (03) 502-511
73 Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009; 50 (06) 1566-1571
74 Kälviäinen R, Allal Z, Kantanen A-M. When is it time for palliative and end-of-life care in status epilepticus?. Epilepsy Behav 2023; 141: 109058
75 Sudore RL, Lum HD, You JJ. et al. Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi Panel. J Pain Symptom Manage 2017; 53 (05) 821-832.e1
76 Quill TE, Holloway R. Time-limited trials near the end of life. JAMA 2011; 306 (13) 1483-1484
77 Willems LM, Bauer S, Jahnke K, Voss M, Rosenow F, Strzelczyk A. Therapeutic options for patients with refractory status epilepticus in palliative settings or with a limitation of life-sustaining therapies: a systematic review. CNS Drugs 2020; 34 (08) 801-826
78 Alt-Epping B, Sitte T, Nauck F, Radbruch L. Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC) [in German]. Schmerz 2010; 24 (04) 342-354
79 Tan F, Chen S, Huang L, Chen Y, Wu Y. Continuous palliative sedation in terminally ill patients with cancer: a retrospective observational cohort study from a Chinese palliative care unit. BMJ Open 2023; 13 (05) e071859